Members of the cytokine/growth hormone/prolactin (PRL) receptor superfamily are associated with cytoplasmic tyrosine kinases of the Jak family. For the PRL receptor (PRLR), after PRL stimulation, both the kinase Jak2 and the receptor undergo tyrosine phosphorylation. To assess the role of tyrosine phosphorylation of the PRLR in signal transduction, several mutant forms of the PRLR in which various tyrosine residues were changed to phenylalanine were constructed and their functional properties were investigated. We identified a single tyrosine residue located at the C terminus of the PRLR to be necessary for in vivo activation of PRL-responsive gene transcription. This clearly
indicates that a phosphotyrosine residue in the cytoplasmic domain of a member of the cytokine/growth hormone/PRL receptor superfamily is directly involved in signal transduction.
The prolactin receptor (PRLR) is a member of the cytokine growth hormone (GH)/PRL receptor superfamily (1) . Members of this family do not contain any intrinsic catalytic domain (such as tyrosine or serine/threonine kinase) but have been shown to associate with cytoplasmic tyrosine kinases from the Jak family that are necessary for signal transduction (for review, see ref.
2). For the PRLR, the receptor constitutively associates with the tyrosine kinase Jak2 (3) (4) (5) (6) . In addition, PRL-induced activation of Jakl has also been reported in BAF-3 cells (5) . We have shown (4) that upon PRL stimulation in Nb2 cells, the associated kinase Jak2 is activated, resulting in the tyrosine phosphorylation of both the kinase and the receptor, and that phosphorylation of both Jak2 and PRLR was time-and dose-dependent in the Nb2 cell line. Moreover, in 293 cells (human embryonic kidney cells), transiently cotransfected with the cDNAs encoding Jak2 and PRLR, both the receptor and the kinase are basally tyrosine-phosphorylated, due to the high level of expression of Jak2. However, upon PRL stimulation, a significant increase in tyrosine phosphorylation of both Jak2 and the PRLR is observed (36) .
Recently, it has also been reported for several members of the family that upon ligand stimulation, the receptors themselves undergo tyrosine phosphorylation (7) (8) (9) (10) (11) (12) . The functional significance of this event still remains poorly understood. Phenylalanine replacement of the C-terminal tyrosine of the cytoplasmic domain of the interferon ry (IFN--y) receptor, a member of the cytokine receptor superfamily, results in a nonfunctional receptor (13) . Recent studies have indicated that growth factors and cytokines, including PRL, may regulate gene expression through direct phosphorylation of a group of Src-homology domain 2 (SH2)-containing latent cytoplasmic transcription factors known as Stat proteins (14) (15) (16) (17) (18) (19) (20) . It has been suggested that signal specificity may be achieved through the activation of Stat molecules that can transactivate different sets of genes. Such a transcription factor termed mammary gland factor (MGF or Stat5) has recently been implicated in
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PRL-dependent transactivation of the f3-casein gene promoter (21, 22) . However, the possible involvement of receptor tyrosine phosphorylation in selecting specific signaling pathways remains unclear.
The PRLR is present in many different tissues and exists in several forms, depending on the species. In the rat, three natural forms of the PRLR have been identified: a short form of 291 aa (23), a long form of 591 aa, which differs from the short form by only the C-terminal tail (24) , and the Nb2 form, which was identified in the Nb2 lymphoma cell line and represents an isoform of the long PRLR, lacking 198 aa due to a genetic deletion in the last exon encoding the receptor (25) . Of these three forms of PRLR, only the long and Nb2 forms are able to transmit a lactogenic signal, as measured by stimulation of the f3-casein or ,B-lactoglobulin promoters (26, 27) , or to induce the interferon regulatory factor 1 promoter (28) . We have recently shown that only the two (long and Nb2) forms were tyrosine-phosphorylated upon PRL stimulation (ref. 36 and Fig. 1 ). In addition, we demonstrated that deletion of the C-terminal part of the Nb2 form of the PRLR (mutant T322; Fig. 1 ) resulted in the loss of activation of the ,B-casein promoter and in the loss of tyrosine phosphorylation of the receptor itself, without affecting either association or activation of the kinase Jak2. This indicates a clear correlation between receptor phosphorylation and activation of gene transcription (36) .
To examine the importance of single phosphotyrosine residues present in the receptor itself, we constructed several mutant forms of the PRLR in which tyrosine residues have been changed to phenylalanine. Transfection of the cDNA encoding these mutants in the 293 cell line stably expressing the tyrosine kinase Jak2 (line LA; ref. 36 ) and precipitation of PRLR complexes using biotinylated PRL and streptavidin to increase sensitivity reveals that the tyrosine phosphorylation of the receptor is a necessary event for activation of gene transcription by PRLR. In addition, we show here that a single tyrosine residue at the C-terminal end of the receptor (Tyr-382 in the Nb2 form and Tyr-580 in the long form) promotes this activation of the ,B-casein promoter, in response to PRL.
MATERIALS AND METHODS
Mutagenesis Experiments. The construction of the tyrosine mutants used the Nb2, A296-322, and long PRLR cDNA and the pR/CMV vector (Invitrogen) as a template. Singlestranded DNA was generated by using the origin of replication of the M13 phages, present on the pR/CMV vector, in the (dut-, ung-) Escherichia coli CJ236 strain, in the presence of the MKO7 M13 helper phage. Mutagenesis was done by the method of Kunkel (29) . The mutated cDNAs were confirmed by sequencing using the 
RESULTS AND DISCUSSION
As summarized in Fig. 1 , we recently observed a correlation between receptor tyrosine phosphorylation and the capacity of the receptor to transmit PRL signals to activate gene transcription (36) . Of the three natural forms of the PRLR (long, short, and Nb2; refs. [23] [24] [25] , only the long and Nb2 forms are able to activate the ,B-casein promoter (26, 27) and to be tyrosine phosphorylated. Although the short form is able to activate Jak2, it is not phosphorylated, despite the presence of four tyrosine residues in its cytoplasmic domain. The long form, which contains nine tyrosine residues, is phosphorylated, whereas the Nb2 form, which contains only three cytoplasmic tyrosine residues, still retains the ability to be &'I. 4Xv, Proc. Natl. Acad Sci. USA 92 (1995) 4033 tyrosine phosphorylated. In addition, a truncated mutant of the Nb2 form of the PRLR (T322), in which the last 70 C-terminal amino acids including the C-terminal tyrosine are missing, is unable to activate the ,3-casein promoter and to be itself tyrosine phosphorylated. In contrast, the deletion mutant A296-322, in which 27 aa, including Tyr-309, are missing, still activates the ,B-casein promoter and is itself phosphorylated (36) . This indicates that phosphorylation of at least two cytoplasmic tyrosine residues (Tyr-237 and Tyr-382 in the Nb2 form) might play a role in signal transduction.
We constructed several mutant forms of the long, Nb2, and A296-322 PRLR, in which the two conserved tyrosine residues were separately mutated to phenylalanine (Fig. 2) Fig. 3A indicate that PRL-stimulated wild-type Nb2 PRLR and the two tyrosine mutant forms (NbY237F and NbY382F) are able to activate Jak2, whereas receptor tyrosine phosphorylation was only observed with the Nb2 and NbY237F forms of PRLR. This indicates that of the three tyrosine residues present in the cytoplasmic domain of the Nb2 PRLR, only the most C-terminal tyrosine is phosphorylated. The cell surface expression of the different forms of receptor was confirmed by probing the membrane with a monoclonal antibody (U5; ref. 4 ) directed against the extracellular domain of the PRLR (Fig. 3B) .
To confirm this finding, we also mutated these two tyrosines in the deletion mutant A296-322. As shown in In contrast, mutation of the last tyrosine residue (Y382F) completely abolished receptor phosphorylation. These results again confirm that only the C-terminal tyrosine (Tyr-382) of the Nb2 form of the receptor undergoes phosphorylation. Correct expression of all forms of PRLR is demonstrated in Fig. 3D .
Finally, we extended our analysis to the long form of the PRLR. For that purpose, we mutated Tyr-237 and Tyr-580 of the long form, homologous to Tyr-237 and Tyr-382 of the Nb2 form, to phenylalanine (Fig. 2) . Interestingly, none of the mutations affected receptor phosphorylation (Fig. 3E) . This indicates that, in contrast to the Nb2 form, the long form of the PRLR contains one or more tyrosine residues able to undergo phosphorylation.
To assess the functional capacity of these mutants to transmit a signal leading to transcriptional activation of PRLresponsive genes, we cotransfected cDNAs encoding different forms of the PRLR with the cDNA encoding the ,B-casein promoter coupled to the luciferase gene and the cDNA encoding for the 3-galactosidase. The results shown in Fig. 4 clearly demonstrate that, for all the forms of PRLR examined including the long form, mutation of the C-terminal tyrosine to phenylalanine markedly reduces the capacity of the receptor to transmit the transcriptional response to PRL. In contrast, replacement of Tyr-237 has no effect on the ability of the different forms of PRLR to respond to PRL stimulation. These data closely parallel those reported for the IFN-y receptor, by demonstrating that of the five intracellular tyrosines, the last was the sole tyrosine required for receptor activity (13) . The fact that other tyrosine(s) of the long form of the PRLR are phosphorylated (Fig. 3E) , whereas the ability of the receptor to activate 13-casein transcription is markedly reduced, suggests that they are probably involved in some other signaling pathway, in agreement with the broad range of biological activities of PRL. Similar results have been observed with the IFN-,y receptor a chain, in which several tyrosine residues are phosphorylated but only the most C-terminal residue is required for IFN--y receptor signal transduction (32) .
This C-terminal phosphotyrosine is likely to be a binding site for a transducer molecule involved in the activation of milk gene transcription. Such transducer molecules usually contain one or several regions of homology to a noncatalytic domain of the Src molecule, called an SH2 domain. These SH2 domains recognize and bind to a phosphotyrosine residue within a specific stretch of amino acids (33) . Recently, consensus binding sites of many SH2-domain-containing transducer molecules have been established (34 (35)], and StatS [also known as mammary gland factor or MGF (21, 22) ]. Statl is activated through Jak2 (36), but little is known about the activation of Stat5. It is possible that StatS could bind directly to the C-terminal phosphotyrosine of the receptor through its own SH2 domain, but this remains to be confirmed. This has been shown, for IFN--y receptor, for which phosphorylation of the C-terminal tyrosine is necessary for binding and activation of Statl (32) . Thus, these data indicate that mutation of a single phosphotyrosine within the cytoplasmic domain of the PRLR is detrimental to activation of gene transcription. This strongly suggests that phosphotyrosines present in the cytoplasmic domains of the members of the cytokine/GH/PRL receptor superfamily might play a critical role in signal transcription. This observation provides one possible explanation for determining signal specificity for members of this receptor superfamily.
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